Daxor Corporation to Present at the 13th Annual LD Micro Main Event 2020
December 09, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status
December 03, 2020 11:54 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 03, 2020 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for...
CVRx® Announces New CFO and Acceleration of Barostim Therapy Commercialization Efforts
November 18, 2020 14:56 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- CVRx, Inc., developer of FDA-approved Barostim Therapy to treat chronic heart failure (HF), announced a CFO transition as part of the company’s...
Study: Combining Brain Training and Walking Helps Heart Failure Patients
October 20, 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, Oct. 20, 2020 (GLOBE NEWSWIRE) -- A new study from Emory University found a combined therapy of brain training and aerobic exercise improved multiple measures that drive better health...
CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19
October 07, 2020 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions Initiatives at HFSA 24th Annual Scientific Meeting Highlight Aquadex Therapy Performance in Heart Failure
September 30, 2020 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Sept. 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions’ Physician-Led Webinar Concludes Fluid Overloaded Heart Failure Patients Benefit from Ultrafiltration
September 10, 2020 09:15 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Sept. 10, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions Continues Physician-Led Webinar Series Discussing Precise Management of Fluid Overload in Patients with Acute Heart Failure
September 03, 2020 08:00 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Sept. 03, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
August 13, 2020 07:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
CMHC Concludes CMHC West Live Online: Complexities in Cardiometabolic Care.
August 11, 2020 12:00 ET
|
Cardiometabolic Health Congress
Boca Raton, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- CMHC Concludes CMHC West Live Online: Complexities in Cardiometabolic Care. CMHC West Live Online: Complexities in Cardiometabolic Care concluded...